Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Заявленная компания
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions читать еще
Stock. Additional stock would be great incentive.
Каковы самые лучшие качества в вашей команде?
My team works hard, is dedicated and supportive of one another.
Что вам больше всего нравится в команде руководства?
The team is nimble and willing to take swift action with matters that affect business.
Что приносит вам больше всего счастья/радости на работе?
It’s fulfilling to pull through initiatives and projects successfully. It’s also nice to feel appreciated or recognition for succe
Что самое позитивное вы можете сказать о культуре и обстановке на вашей работе?
Executive team is supportive and generally willing to take swift action when needed. Innovation and urgency enable a healthy nimble environment.
Other Employee Reviews for Karyopharm Therapeutics
×